1. Home
  2. TARS vs WERN Comparison

TARS vs WERN Comparison

Compare TARS & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • WERN
  • Stock Information
  • Founded
  • TARS 2016
  • WERN 1956
  • Country
  • TARS United States
  • WERN United States
  • Employees
  • TARS N/A
  • WERN N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • WERN Trucking Freight/Courier Services
  • Sector
  • TARS Health Care
  • WERN Industrials
  • Exchange
  • TARS Nasdaq
  • WERN Nasdaq
  • Market Cap
  • TARS 1.8B
  • WERN 1.7B
  • IPO Year
  • TARS 2020
  • WERN N/A
  • Fundamental
  • Price
  • TARS $40.65
  • WERN $27.25
  • Analyst Decision
  • TARS Strong Buy
  • WERN Hold
  • Analyst Count
  • TARS 7
  • WERN 13
  • Target Price
  • TARS $67.14
  • WERN $31.15
  • AVG Volume (30 Days)
  • TARS 552.3K
  • WERN 866.0K
  • Earning Date
  • TARS 08-07-2025
  • WERN 07-29-2025
  • Dividend Yield
  • TARS N/A
  • WERN 2.05%
  • EPS Growth
  • TARS N/A
  • WERN N/A
  • EPS
  • TARS N/A
  • WERN 0.29
  • Revenue
  • TARS $233,674,000.00
  • WERN $2,973,292,000.00
  • Revenue This Year
  • TARS $122.94
  • WERN $0.55
  • Revenue Next Year
  • TARS $44.14
  • WERN $6.33
  • P/E Ratio
  • TARS N/A
  • WERN $95.02
  • Revenue Growth
  • TARS 449.03
  • WERN N/A
  • 52 Week Low
  • TARS $20.08
  • WERN $23.02
  • 52 Week High
  • TARS $57.28
  • WERN $42.48
  • Technical
  • Relative Strength Index (RSI)
  • TARS 40.26
  • WERN 49.50
  • Support Level
  • TARS $39.25
  • WERN $26.85
  • Resistance Level
  • TARS $42.01
  • WERN $28.52
  • Average True Range (ATR)
  • TARS 1.93
  • WERN 0.94
  • MACD
  • TARS -0.05
  • WERN 0.10
  • Stochastic Oscillator
  • TARS 22.95
  • WERN 54.32

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About WERN Werner Enterprises Inc.

Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - Truckload Transportation Services and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.

Share on Social Networks: